Edoxaban tosylate monohydrate chemical structure
Chemical structureResearch use only
CAT. NO. DC8793Featured

Edoxaban tosylate monohydrate

Pack Sizes & Prices

TotalUS$450
We match the best price and quality on market.
Product overview

Description & Application

Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention

ParameterValue
Chemical NameEdoxaban tosylate monohydrate
CAS No.1229194-11-9
SynonymsEdoxaban tosilate;Edoxaban;Edoxaban (tosylate monohydrate);Edoxaban tosilateEdoxaban tosilate;Edoxaban Tosylate Monohydrate;N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide,4-methylbenzenesulfonic acid,hydrate;N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide mono(p-toluenesulfonate) monohyd;CS-1333;Edoxaban tosilate hydrate (JAN);Edoxaban tosilate monohydrate;Lixiana;LIXIANA (TN);N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-[(dimethyl amino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-toluenesulfonate monohydrate;edoxaban tosylate hydrate;Edoxaban tosilate hydrate;SAVAYSA;972203R4EW;AK171134;Savaysa (TN);Edoxaban p-toluenesulfonate monohydrate;edoxaban-tosylate-monohydrate;AOB6678;PSMMNJNZVZZNOI-SJILXJHISA-N;BCP15112
FormulaC31H40ClN7O8S2
M.Wt738.2744
SMILESClC1=C([H])N=C(C([H])=C1[H])N([H])C(C(N([H])[C@@]1([H])C([H])([H])C([H])([H])[C@]([H])(C(N(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])[C@@]1([H])N([H])C(C1=NC2C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C=2S1)=O)=O)=O.S(C1C([H])=C([H])C(C([H])([H])
Purity99%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheetRequest COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

Edoxaban chemical structureDC8305

Edoxaban

Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal…

View activity & prices
PF-06282999 chemical structureDC10500

PF-06282999

PF-06282999 is a potent and selective myeloperoxidase inhibitor which is potential useful for the treatment of cardiovascular diseases.

View activity & prices
Cangrelor free acid chemical structureDC7005

Cangrelor free acid

Cangrelor is a P2Y12 inhibitor, and was approved in June 2015 as an antiplatelet drug for intravenous application. Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete…

View activity & prices

Cart

Request quotation